Glucocorticoid-induced osteoporosis: hope on the HORIZON - The Lancet
New FDA approval: Tymlos (abaloparatide) for Osteoporosis — GT Health, Endocrinology
Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide - ScienceDirect
Teriparatide | Nature Reviews Drug Discovery
Osteoporosis therapies and their mechanisms of action (Review)
Romosozumab in the treatment of osteoporosis | Immunotherapy
Osteoporosis and teriparatide
IJMS | Free Full-Text | Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review | HTML
Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis | Nature Reviews Endocrinology
Mechanisms of Anabolic Therapies for Osteoporosis | NEJM
Parathyroid hormone analogues in the treatment of osteoporosis | Nature Reviews Endocrinology
IJMS | Free Full-Text | Molecular Mechanisms and Emerging Therapeutics for Osteoporosis | HTML
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial - The Lancet
Mechanisms of Anabolic Therapies for Osteoporosis | NEJM
Osteoporosis medications | Osmosis
Teriparatide
Osteoanabolic and dual action drugs - Tabacco - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library
IJMS | Free Full-Text | Anabolic Therapies in Osteoporosis and Bone Regeneration | HTML
Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide | SpringerLink
IJMS | Free Full-Text | Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review | HTML
Abaloparatide and the Spine: A Narrative Review | CIA
Osteoporosis and teriparatide
Medications That Affect Calcium - Endocrine Practice
Bone forming drug Pol.Maj.Dr. Tanawat amphansap - ppt download
